Treebough Therapies
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS) (NCT07006025) | Treebough Therapies | 2025-06-03 |
Track Treebough Therapies automatically
Every clearance here is in the API, with alerts when new ones post.